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ABSTRACT
Background There is virtually no limit to the number 
of innovations being developed, tested and piloted at 
any one time to improve the quality and safety of care. 
The perennial problem is spreading innovations that 
are proven to be effective on a smaller scale or under 
controlled conditions. Much of the literature on spread 
refers to the important role played by external agencies 
in supporting the spread of innovations.
Academic Health Science Networks and the 
spread of innovation External agencies can 
provide additional capacity and capabilities to adopter 
organisations, such as technical expertise, resources and 
tools to assist with operational issues. In England, the 
National Health Service (NHS) established 15 Academic 
Health Science Networks (AHSNs) to help accelerate 
the spread and adoption of innovation in healthcare. 
However, formal clinical- academic networks (such as 
AHSNs) themselves will not deliver positive, tangible 
outcomes on the ground (ie, evidence- based innovations 
embedded at scale across a system). This begs the 
question of how do AHSNs practically go about achieving 
this change successfully? We provide an AHSN’s 
perspective on how we conceptualise and undertake our 
work in leading implementation of innovation at scale.
An AHSN's perspective Our approach is a 
collaborative process of widening understanding of 
the innovation and its implementation. At its core, the 
implementation and spread of innovation into practice is 
a collective social process. Healthcare comprises complex 
adaptive systems, where contexts need to be negotiated 
for implementation to be successful. As AHSNs, we aim 
to lead this negotiation through facilitating knowledge 
exchange and production across the system to mobilise 
the resources and collective action necessary for 
achieving spread.
INTRODUCTION
During 2013–2014, NHS England established 
15 Academic Health Science Networks (AHSNs) 
to help accelerate the spread and adoption of 
innovation in healthcare. The role of AHSNs is 
to deliver a step change in the way the NHS and 
social care identify, and to develop and adopt 
existing evidence- based innovations at scale. It is 
left to each of the AHSNs to determine how this 
is best achieved locally. However, formal clinical- 
academic networks (such as AHSNs) themselves 
will not deliver positive, tangible outcomes on the 
ground (ie, evidence- based innovations embedded 
at scale across a system).1 2 This begs the question 
of how do AHSNs practically go about achieving 
this change successfully? We provide an AHSN’s 
perspective on how we conceptualise the spread 
and adoption of innovation and give a case study 
to illustrate how we undertake our work in practice 
to lead scale- up across systems. This draws together 
perspectives from individuals in senior leaderships 
roles involved in the AHSN’s work from across 
clinical, managerial and academic domains (eg, 
medical/clinical directors, a programme director 
and senior academics).
Historically, the research and innovation ‘pipe-
line’ has been geared towards a push model and 
consequently we see virtually no limit to the number 
of innovations being developed, tested and piloted 
at any one time. More recently, we are seeing a shift 
towards focusing on articulating needs more clearly 
and identifying (or developing) innovations that 
appropriately address these needs.3 4 However, the 
perennial problem remains as to how innovations 
can be implemented at scale to deliver intended 
benefits effectively.5
Much of the literature on spread refers to the 
important role played by external agencies in 
supporting the spread of innovations.6 7 External 
agencies can provide additional capacity and capa-
bilities to adopter organisations, such as tech-
nical expertise, resources and tools to assist with 
operational issues.6 8 Spread is also supported by 
continuous relationship building and partnership 
development activities.9 Therefore, part of the way 
organisations can work most effectively to support 
the spread of innovations is by developing partner-
ships, collaborations and networks with key stake-
holders.10 11
CONCEPTUALISING SPREAD AND ADOPTION: 
AN AHSN PERSPECTIVE
Our experience as the AHSN for South London 
(or Health Innovation Network) resonates with the 
literature that there is no one ‘right way’ to imple-
ment innovations at scale,5 and that spread and 
adoption is a non- linear, iterative, participatory and 
resource- intensive process.5 9 12 At its core spread is 
a process about building capacity and capabilities 
at multiple levels: individuals, organisations and 
systems.5 8 13 For spread to be effective it needs to be 
a planned, resourced and managed approach, where 
consideration is given to developing the infrastruc-
ture required to support the individuals, organisa-
tions and systems involved in the process.6 9
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While spread efforts are a planned process underpinned by 
sound project and programme management, there also has 
to be a large amount of pragmatism to ‘make it happen’. Our 
approach is underpinned by an ethos of working with the willing 
and remaining open to unforeseen opportunities. The need for 
flexibility is necessary to be able to respond to the turbulence and 
continuous change within the wider system.14 Complexity theory 
recognises the limits of using formally planned approaches in 
complex adaptive systems, which have a countless array of parts 
and interdependencies that lead to unforeseen outcomes.1 15 16 
It accepts that local contextual factors are difficult to influence 
as they are emergent, dynamic and self- organising.1 15–17 As a 
consequence, for interventions to spread we need to understand 
local variation and focus on adapting interventions to integrate 
into individual practice settings, rather than hold an uncompro-
mising preoccupation with standardisation.15 17
At its core, the implementation and spread of innovation into 
practice is a collaborative, collective social process.18 19 The 
implementation of evidence into practice has typically been 
approached as a problem of knowledge transfer where the issue 
lies in the dissemination of knowledge from research to prac-
tice.20 However, this framing ignores that practitioners create 
their own knowledge through their own experiences. It may be 
more helpful to reframe it as a problem of knowledge produc-
tion. All parties have partial and different knowledge; there-
fore, exchange and interaction by all parties is needed to create 
meaningful and actionable knowledge that is context- specific 
and purpose- specific.20 This relies on shifting from a narrow 
concept of knowledge to include informal and tacit knowl-
edge.21 22 Kitson and colleagues suggest we move away from 
the idea of a ‘gap’, where users (as passive and peripheral recip-
ients) and producers of knowledge or innovation engaged in 
push- pull activities, to a ‘space’ or ‘synapse of interaction and 
connectivity’.1
Using this conceptualisation, as an AHSN we work to draw 
on our own and providers’ practical experience of implementing 
innovation and combine this with formal evidence (eg, research 
and evaluation), to reconstruct and evolve knowledge about the 
intervention and how to implement it across multiple contexts 
to achieve scale- up.18 Our approach is to understand and drive 
the adaptive work needed to implement innovations success-
fully in different contexts, in order to support spread.17 This 
largely focuses on ways to test spread by exploring and evalu-
ating elements relating to where the intervention is delivered, 
who delivers it, to whom it is targeted and how best to share this 
knowledge with prospective adopters and commissioners.
Perhaps the best analogy to illustrate our work is gardening. 
The role of AHSNs is like expert gardeners or cultivators in a 
complex landscape. A need is identified that every patient in the 
country should have ready access to a new variety of tomato. 
There is a vision of this new crop being grown in every place 
in the land, but unfortunately there are very few vacant fields 
and the soil is in various levels of readiness or appropriateness 
to grow this particular variety of tomato. So AHSNs are asked 
to support. We know the land. We help prepare the ground. We 
make sure we understand the plant and also what the plant is due 
to provide, and whether there are other varieties that might be 
more appropriate for certain conditions.
The approach to our groundwork is founded on the insights 
of clinical academics in implementation science. Our theory 
of change—the reasoning behind why we think our chosen 
approach is going to get us from A to B—depends on the unique 
circumstances present. The nature of spread and adoption work 
varies based on the specific innovation, barriers, enablers and 
knowledge in the system. Thus, we do not use the same approach 
all the time or everywhere.
Being part of a network of AHSNs, which have grown up 
with a variety of approaches, is a strength and something the 
AHSN network capitalises on. We are skilled in collaborative 
working; expert in building trust among people across different 
organisations and parts of the system. It is important that our 
organisation does not performance manage our members and 
we make it clear that we use data and information to motivate 
change and bring insight rather than judge—while at times 
harnessing healthy competition between organisations who are 
then enabled by us to learn from one another.
Spread and adoption in practice: an AHSN case study
We support the spread and adoption of a wide range of inno-
vations across a diverse number of settings: service- level inter-
ventions, digital platform for referrals, patient safety devices 
and new diagnostic tests that change care pathways. The 
AHSNs also coordinate to support the scale- up of a set of 
national programmes (eg, PReCePT—Preventing cerebral palsy 
in preterm babies; PINCER—Preventing prescribing errors 
in primary care; Serenity Integrated Mentoring—Supporting 
people with complex behavioural disorders who place high 
demands on emergency services and mental health teams). We 
will use one of these national programmes, ESCAPE- pain, as a 
case study to illustrate how AHSNs work in practice to achieve 
scale- up.
The problem and the intervention: osteoarthritis and the 
ESCAPE-pain programme
There are approximately 8.75 million people in the UK living 
with osteoarthritis (OA) and this is projected to increase to 17 
million by 2030.23 24 OA is a major cause of disability with a 
large socioeconomic burden.25 Despite National Institute for 
Health and Care Excellence (NICE) guidance26 and proven inter-
ventions (such ESCAPE- pain), the management of OA remains 
suboptimal because the evidence base is not being implemented 
into practice.27 28 ESCAPE-pain promotes self- management 
to improve quality of life and function.29–31 The programme 
is delivered over 6 weeks via 2 weekly group sessions that last 
45–60 min (with 15–20 min of structured education and 30–45 
min of individualised exercise). ESCAPE- pain was shown to be 
clinically and cost- effective through a large cluster randomised 
controlled trial and economic evaluation.29 30 32
AHSN involvement in spread
In 2014, ESCAPE- pain was selected by the AHSN for South 
London (Health Innovation Network) as a priority for local 
scale- up. In April 2018, it became a national programme for 
scale- up supported by England’s 15 AHSNs for a 2- year period. 
Scale- up was coordinated by a national programme manager and 
locally dedicated resource (eg, project manager, clinical cham-
pion) within each AHSN.
Scale of spread achieved
Following the AHSN Network national programme, ESCAPE- 
pain is now being delivered in 260 sites with over 16 000 people 
with hip and knee OA completing the programme. This is a 
fourfold increase in the number of sites and threefold increase 
in the number of participants compared with the start of the 
national programme in April 2018. The growth in sites during 
2018–2020 has been accompanied by a substantial expansion 
in geographical spread beyond London and South- East England 
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to include sites across all regions in England. This spread has 
been accompanied by an expansion in the models of delivery for 
ESCAPE- pain across an increasing range of settings (NHS and 
non- clinical community), providers (NHS, community leisure, 
local authority) and practitioners (physiotherapists, therapy 
assistants and fitness professionals) eg, 53.5% of sites delivering 
the programme are non- clinical, community settings. Critically, 
monitoring of clinical outcomes demonstrates that ESCAPE- 
pain continues to be clinically effective in ‘real world’ settings at 
levels comparable to the original randomised controlled trial.33
Coordinating the AHSN’s national programme for ESCAPE-
pain
The approach to coordinating the AHSN national programme 
for ESCAPE- pain has been underpinned by developing a cohe-
sive partnership between AHSNs via peer support and knowl-
edge sharing. The ESCAPE- pain core team based at the South 
London AHSN used a range of approaches (eg, regular webi-
nars, face- to- face learning network meetings, FutureNHS collab-
orative online platform, annual review and planning meetings) 
to allow existing knowledge about spreading ESCAPE- pain to 
be shared, and to capture and exchange learning that emerged 
from the AHSN Network during the national programme (eg, 
local contextual issues, strategies for local spread). Collectively, 
the AHSNs used this learning to develop a suite of resources 
to support local spread efforts (eg, resources for commissioners 
with cost modelling, an implementation toolkit for providers, 
patient case studies and marketing materials).
In addition, the AHSNs developed a coordinated national 
monitoring programme to evaluate the scale and impact of 
spread (eg, collecting data on the number of sites, location of 
sites, type of provider and site, number of cohorts and partici-
pants and pre/post clinical outcomes). This has required signifi-
cant investment in developing and maintaining monitoring and 
evaluation activities and infrastructure.
AHSNs’ approaches to implementing and scaling up ESCAPE-
pain
We know from the literature that implementation strategies 
need to be chosen and tailored to accommodate the charac-
teristics of the intervention, provider (or adopter), the team 
resourced to support implementation and the wider system (or 
environment).34–36 Key strategies used by AHSNs to implement 
ESCAPE- pain successfully were:
 ► Developing stakeholder interrelationships—Identifying and 
supporting local champions and early adopters, building 
local partnerships and consensus for ESCAPE- pain (ie, iden-
tifying and agreeing the need and fostering a commitment 
and urgency to implement) and working with partners from 
across the system (eg, providers and commissioners from the 
NHS, local authority, and leisure and community sector).
 ► Training and education—Developing and rolling out a 
mandatory 1 day training course on how to deliver and 
implement the programme, developing a suite of tailored 
and packaged resources about the evidence, delivery and 
implementation of ESCAPE- pain. This involved developing 
a national network of trainers (largely drawn from local 
champions and the national team).
 ► Using financial measures—Funding and contracting for 
ESCAPE- pain, for example, embedded it within tenders, 
payment for delivering the programme and providing free 
training.
 ► Providing interactive assistance—Local AHSNs and the 
national team providing ongoing technical assistance to part-
ners to support implementation. This included providing 
information and support around decision- making to adopt 
(eg, business case templates, attending key meetings), 
resources and advice on implementation and delivery (eg, 
implementation toolkit, site visits), and helping to problem- 
solve any issues impeding implementation.
 ► Using evaluation and iterative strategies—A key approach 
used by AHSNs has been to test and refine different ways 
of implementing ESCAPE- pain, to identify and share key 
barriers and facilitators, and learn about what works across 
a variety of settings and delivery models (eg, exercise on 
referrals schemes, NHS- leisure provider partnerships). The 
ongoing monitoring of ESCAPE- pain has facilitated scale- up 
by providing evidence to key decision makers about its 
clinical effectiveness and cost- effectiveness in ‘real world’ 
settings.
AHSNs’ choice of strategies was determined by a range of 
factors, such as the characteristics of providers (eg, NHS, non- 
NHS community), the resources allocated within the AHSN to 
support work on ESCAPE- pain and the wider system (eg, extent 
of (dis)engagement by commissioner and key strategic decision 
makers). Determining and deploying appropriate strategies 
required AHSNs to (1) Be clear about their offer to local systems, 
including the level of resource available to support local imple-
mentation efforts; (2) Clarify the scope of focus to their work on 
ESCAPE- pain, that is, targeting specific parts of the system (eg, 
only NHS providers) versus casting the net more widely; and 
(3) Recognise the need for a multifaceted approach that engages 
directly with providers, as well as operating at a system level (eg, 
commissioners, interorganisational partnership).
It is important to note that ESCAPE- pain has not been 
successfully spread in all locations, where key barriers have been 
intractable and/or too many in number (ie, a ‘perform storm’ of 
barriers). The factors most consistently encountered by AHSNs 
that impede the local scale- up of ESCAPE- pain were: (1) Current 
(predominant) funding models that are activity based and prior-
itise in- year cost savings within commissioners’ budgets. These 
models do not readily support the implementation of new inter-
ventions (such as ESCAPE- pain), which require greater upfront 
investment compared with incumbent interventions and may 
realise benefits in the long term and across health and social care 
systems; (2) Attitudes towards evidence and evidence- based prac-
tice, particularly among senior managers and senior clinicians. 
Despite existing local alternative programmes having limited 
(or no) evidence of clinical effectiveness and cost- effectiveness, 
appetite for change could be low resulting in an unwillingness to 
replace their own programme with ESCAPE- pain.
CONCLUSION
The idea of the movement of research and innovation into prac-
tice as a pipeline is a poor conceptualisation of what happens in 
practice; the reality is a much messier and non- linear process. 
Our experience of the spread and adoption is that of a collec-
tive process underpinned by a process of exchanging knowledge 
(both formal and tactic) across systems. This process aims to 
build consensus and understanding about needs, viable solu-
tions (or innovations) and their implementation. The spread of 
innovation is also about trying to understand local variation, but 
contextual factors are difficult to influence as they are dynamic 
and self- organising driven by the interactions and relationships 
between the components of the system. This makes it difficult 
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to have a universal ‘blueprint’ for our work. In practice, our 
approach is to use strategies that deliberately support collabora-
tion, flexibility and partnership. By actively facilitating greater 
connectivity we can support systems to negotiate and mobilise 
the resources (eg, knowledge, financial, relational) needed to 
spread and adopt innovation successfully.
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